• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group.

出版信息

Arch Ophthalmol. 1993 Jan;111(1):104-9. doi: 10.1001/archopht.1993.01090010108035.

DOI:10.1001/archopht.1993.01090010108035
PMID:7678730
Abstract

We evaluated the hypothesis that higher serum levels of micronutrients with antioxidant capabilities may be associated with a decreased risk of neovascular age-related macular degeneration by comparing serum levels of carotenoids, vitamins C and E, and selenium in 421 patients with neovascular age-related macular degeneration and 615 controls. Subjects were classified by blood level of the micronutrient (low, medium, and high). Persons with carotenoid levels in the medium and high groups, compared with those in the low group, had markedly reduced risks of neovascular age-related macular degeneration, with levels of risk reduced to one half and one third, respectively. Although no statistically significant protective effect was found for vitamin C or E or selenium individually, an antioxidant index that combined all four micronutrient measurements showed statistically significant reductions of risk with increasing levels of the index. Although these results suggest that higher blood levels of micronutrients with antioxidant potential, in particular, carotenoids, may be associated with a decreased risk of the most visually disabling form of age-related macular degeneration, it would be premature to translate these findings into nutritional recommendations.

摘要

相似文献

1
Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group.
Arch Ophthalmol. 1993 Jan;111(1):104-9. doi: 10.1001/archopht.1993.01090010108035.
2
Serum antioxidants and age-related macular degeneration in a population-based case-control study.一项基于人群的病例对照研究中的血清抗氧化剂与年龄相关性黄斑变性
Arch Ophthalmol. 1995 Dec;113(12):1518-23. doi: 10.1001/archopht.1995.01100120048007.
3
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.膳食类胡萝卜素、维生素A、C和E与年龄相关性黄斑变性。眼病病例对照研究组。
JAMA. 1994 Nov 9;272(18):1413-20.
4
[Antioxidants and angiogenetic factor associated with age-related macular degeneration (exudative type)].
Nippon Ganka Gakkai Zasshi. 1997 Mar;101(3):248-51.
5
Dietary Habits, Fatty Acids and Carotenoid Levels Are Associated with Neovascular Age-Related Macular Degeneration in Chinese.饮食习惯、脂肪酸和类胡萝卜素水平与中国人的年龄相关性黄斑变性的新生血管有关。
Nutrients. 2019 Jul 25;11(8):1720. doi: 10.3390/nu11081720.
6
Sunlight exposure, antioxidants, and age-related macular degeneration.阳光照射、抗氧化剂与年龄相关性黄斑变性
Arch Ophthalmol. 2008 Oct;126(10):1396-403. doi: 10.1001/archopht.126.10.1396.
7
Serum levels of antioxidants and age-related macular degeneration.血清抗氧化剂水平与年龄相关性黄斑变性
Doc Ophthalmol. 1992;81(4):387-400. doi: 10.1007/BF00169100.
8
Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group.
Arch Ophthalmol. 1992 Dec;110(12):1701-8. doi: 10.1001/archopht.1992.01080240041025.
9
Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration.新生血管性年龄相关性黄斑变性患者眼部黄斑区视网膜色素上皮中的抗氧化酶
Am J Ophthalmol. 1999 Jun;127(6):694-709. doi: 10.1016/s0002-9394(99)00032-x.
10
Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age.
Arch Ophthalmol. 1999 Oct;117(10):1384-90. doi: 10.1001/archopht.117.10.1384.

引用本文的文献

1
Free Radicals in Health and Disease.健康与疾病中的自由基
MedComm (2020). 2025 Sep 21;6(10):e70396. doi: 10.1002/mco2.70396. eCollection 2025 Oct.
2
The Role of Oral Supplementation for the Management of Age-Related Macular Degeneration: A Narrative Review.口服补充剂在年龄相关性黄斑变性管理中的作用:一项叙述性综述。
J Pers Med. 2024 Jun 18;14(6):653. doi: 10.3390/jpm14060653.
3
Bioavailability of Lutein from Marigold Flowers (Free vs. Ester Forms): A Randomised Cross-Over Study to Assess Serum Response and Visual Contrast Threshold in Adults.
叶黄素从万寿菊花中(游离态与酯化态)的生物利用度:评估成人血清应答和视觉对比阈值的随机交叉研究。
Nutrients. 2024 May 8;16(10):1415. doi: 10.3390/nu16101415.
4
Oxidative Stress and Antioxidants in Age-Related Macular Degeneration.年龄相关性黄斑变性中的氧化应激与抗氧化剂
Antioxidants (Basel). 2023 Jul 3;12(7):1379. doi: 10.3390/antiox12071379.
5
Carotenoids in Drug Discovery and Medicine: Pathways and Molecular Targets Implicated in Human Diseases.类胡萝卜素在药物发现和医学中的作用:涉及人类疾病的途径和分子靶点。
Molecules. 2022 Sep 15;27(18):6005. doi: 10.3390/molecules27186005.
6
B Vitamins and Incidence of Advanced Age-Related Macular Degeneration: The Alienor Study.B 族维生素与晚期年龄相关性黄斑变性的发生:Alienor 研究。
Nutrients. 2022 Jul 8;14(14):2821. doi: 10.3390/nu14142821.
7
The level and efficacy of lutein in patients with age-related macular degeneration: a comprehensive systematic review and meta-analysis.叶黄素在年龄相关性黄斑变性患者中的水平及疗效:一项全面的系统评价和荟萃分析。
Ann Transl Med. 2022 Mar;10(6):299. doi: 10.21037/atm-22-173.
8
The Associations of Plasma Carotenoids and Vitamins With Risk of Age-Related Macular Degeneration: Results From a Matched Case-Control Study in China and Meta-Analysis.血浆类胡萝卜素和维生素与年龄相关性黄斑变性风险的关联:来自中国一项匹配病例对照研究及荟萃分析的结果
Front Nutr. 2022 Feb 11;9:745390. doi: 10.3389/fnut.2022.745390. eCollection 2022.
9
Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review.探索天然抗氧化剂在年龄相关性黄斑变性中的潜力:综述
Pharmaceuticals (Basel). 2022 Jan 14;15(1):101. doi: 10.3390/ph15010101.
10
Antioxidant supplements in age-related macular degeneration: are they actually beneficial?抗氧化剂补充剂与年龄相关性黄斑变性:它们真的有益吗?
Ther Adv Ophthalmol. 2021 Aug 27;13:25158414211030418. doi: 10.1177/25158414211030418. eCollection 2021 Jan-Dec.